VEGF 3D Structures: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 8: | Line 8: | ||
**[[5hhc]], [[5hhd]] – hVEGF-A 214-315 - human <br /> | **[[5hhc]], [[5hhd]] – hVEGF-A 214-315 - human <br /> | ||
**[[1mkg]], [[1mkk]], [[1mjv]] – hVEGF-A receptor-binding domain (mutant) <br /> | **[[1mkg]], [[1mkk]], [[1mjv]] – hVEGF-A receptor-binding domain (mutant) <br /> | ||
**[[3bdy]], [[2qr0]] - hVEGF-A receptor-binding domain + hFab light+heavy chain <br /> | **[[3bdy]], [[2qr0]], [[6bft]], [[6t9d]] - hVEGF-A receptor-binding domain + hFab light+heavy chain <br /> | ||
**[[4kzn]], [[3qtk]], [[2vpf]], [[1vpf]] - hVEGF-A receptor-binding domain<br /> | **[[4kzn]], [[3qtk]], [[2vpf]], [[1vpf]] - hVEGF-A receptor-binding domain<br /> | ||
**[[2fjg]], [[2fjh]] - hVEGF-A receptor-binding domain + hFab light+heavy chain <br /> | **[[2fjg]], [[2fjh]] - hVEGF-A receptor-binding domain + hFab light+heavy chain <br /> | ||
Line 21: | Line 21: | ||
**[[1qty]], [[1flt]] – hVEGF-A receptor-binding domain + hFMS-like tyrosine <br /> | **[[1qty]], [[1flt]] – hVEGF-A receptor-binding domain + hFMS-like tyrosine <br /> | ||
**[[1vpp]] – hVEGF-A receptor-binding domain + receptor blocking peptide <br /> | **[[1vpp]] – hVEGF-A receptor-binding domain + receptor blocking peptide <br /> | ||
**[[6d3o]] – hVEGF-A receptor-binding domain + HH4 peptide <br /> | **[[6d3o]], [[6v7k]] – hVEGF-A receptor-binding domain + HH4 peptide <br /> | ||
**[[1bj1]] – hVEGF-A receptor-binding domain + mFab light+heavy chain fragments <br /> | **[[1bj1]] – hVEGF-A receptor-binding domain + mFab light+heavy chain fragments <br /> | ||
**[[1kat]] - hVEGF-A receptor binding domain + peptide antagonist - NMR<br /> | **[[1kat]] - hVEGF-A receptor binding domain + peptide antagonist - NMR<br /> |
Revision as of 13:44, 10 January 2021
3D Structures of VEGF3D Structures of VEGF
Updated on 10-January-2021 - For a general description of the protein see Vascular Endothelial Growth Factor